Skip to main content

Glycosaminoglycans as Key Molecules in Atherosclerosis: The Role of Versican and Hyaluronan

Buy Article:

$63.00 plus tax (Refund Policy)

Abstract:

Cardiovascular disease is the largest cause of death in Western societies and it primarily results from atherosclerosis of large and medium-sized vessels. Atherosclerosis leads to myocardial infarction, when it occurs in the coronary arteries, or stroke, when it occurs in the cerebral arteries. Pathological processes involved in macrovascular disease include the accumulation of lipids which are retained by extracellular matrix (ECM) molecules, especially by the chondroitin sulfate/dermatan sulfate (CS/DS) proteoglycans (CS/DSPGs), such as versican, biglycan and decorin. The sulfation pattern of CS is a key player in protein interactions causing atherosclerosis. Several studies have shown that lipoproteins bind CSPGs via their glycosaminoglycan chains. Galactosaminoglycans, such as CS and DS, bind low density lipoproteins (LDL), affecting the role of these molecules in the arterial wall. In this article, the role of CS and versican in atherosclerosis and hyaluronan in atherogenesis as well as the up to date known mechanisms that provoke this pathological condition are presented and discussed.





Keywords: ADAMTS; AoSMCs; Atherosclerosis; CS/DS; CS/DSPGs; Dglucuronic acid; GAGs; GalAGs; Galactosaminoglycans; Glycosaminoglycans; HARE; Hyaluronan; Hyaluronan Receptor for Endocytosis; Hyaluronan-Mediated Motility; LYVE-1; Lymphatic Vessel Endothelial Receptor 1; N-acetyl-D-galactosamine; RHAMM; TFPI-1; TLR4; Tissue Factor Pathway Inhibitor-1; Toll Like Receptors 4; VCAM-1; cellular mechanisms; chondroitin sulfate; chondroitin sulfate/dermatan sulfate; glycosaminoglycans; human aortic smooth muscle cells; lipoproteins; proteoglycans; vascular cell adhesion molecule-1; versican

Document Type: Research Article

DOI: http://dx.doi.org/10.2174/092986710793205354

Publication date: January 1, 2010

More about this publication?
  • Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.
ben/cmc/2010/00000017/00000033/art00004
dcterms_title,dcterms_description,pub_keyword
6
5
20
40
5

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more